EGFR and non-small cell lung carcinoma: Furthermore, KEGG pathway analysis demonstrated the involvement of these DEGs in pivotal pathways like “cytokine–cytokine receptor interaction,” “melanogenesis,” and “basal cell carcinoma.” Intriguingly, cytokine–cytokine receptor interactions have been identified as primary drivers of EGFR–TKI resistance in NSCLC (32).